Trifecta Capital Advisors’s Eli Lilly LLY Stock Holding History

Trifecta Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.6M	Sell	25,631 -93	-0.4%	-$94.3K	3.65%	7
2025 Q4	$27.6M	Buy	25,724 +260	+1%	+$249K	4.09%	6
2025 Q3	$19.4M	Buy	25,464 +683	+3%	+$508K	2.95%	8
2025 Q2	$19.3M	Buy	24,781 +2,712	+12%	+$2.11M	3.22%	7
2025 Q1	$18.2M	Sell	22,069 -74	-0.3%	-$61.6K	3.82%	7
2024 Q4	$17.1M	Buy	22,143 +196	+0.9%	+$162K	3.38%	9
2024 Q3	$19.4M	Buy	21,947 +131	+0.6%	+$118K	4.07%	8
2024 Q2	$19.8M	Buy	21,816 +298	+1%	+$238K	4.37%	7
2024 Q1	$16.7M	Sell	21,518 -1,804	-8%	-$1.28M	4.07%	8
2023 Q4	$13.6M	Sell	23,322 -2,463	-10%	-$1.44M	3.76%	8
2023 Q3	$13.8M	Buy	25,785 +720	+3%	+$371K	4.45%	5
2023 Q2	$11.8M	Sell	25,065 -1,873	-7%	-$785K	3.78%	7
2023 Q1	$9.25M	Buy	26,938 +275	+1%	+$92.7K	3.26%	8
2022 Q4	$9.75M	Buy	+26,663	New	+$9.45M	3.89%	7

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Trifecta Capital Advisors's LLY Position: Q1 2026 in Review

Trifecta Capital Advisors reduced its Eli Lilly (LLY) stake by 0.36% in Q1 2026, selling an estimated $94.3K and leaving 25,631 shares worth $23.6M. The position accounts for 3.65% of the portfolio, ranked #7.

Trifecta Capital Advisors first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $27.6M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Trifecta Capital Advisors held 25,631 shares of Eli Lilly worth $23.6M as of Q1 2026.
Trifecta Capital Advisors sold 93 Eli Lilly shares in Q1 2026, an estimated $94.3K.
Eli Lilly made up 3.65% of Trifecta Capital Advisors's portfolio in Q1 2026, its #7 holding.
Trifecta Capital Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
Trifecta Capital Advisors's Eli Lilly position peaked at $27.6M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Trifecta Capital Advisors's 13F filing for Q1 2026, filed 1 May 2026.